VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Pharmaceutical industry including recent transactions, market multiples, company performance and purchase price allocation percentages.

Industry Highlights

• On November 21, 2024, Novartis announced the $1.1 billion acquisition of Kate Therapeutics, a preclinical-stage biotechnology company that focuses on adeno-associated virus (AAV)-based gene therapies.
• On January 13, 2025, Johnson & Johnson announced the acquisition of Intra-Cellular Therapies for $14 billion. Intra-Cellular Therapies Inc. makes Caplyta, a once-daily pill for treating adults with schizophrenia and depression tied to bipolar disorder.

Past Industry Updates

Pharmaceuticals: July 2024

Pharmaceuticals: February 2024